Shervin R. Dashti, M.D., Ph.D., was able to remove a clot from the patient’s left middle cerebral artery, which was the cause of the patient’s stroke symptoms. Incident details: 75-year-old female Arrived at Norton Brownsboro Hospital 10 p.m. Norton Neuroscience Institute physicians: Mohammad S. Alsorogi, M.D., vascular stroke neurologist; Shervin R. Dashti M.D., Ph.D., neurosurgeon…
The new Norton Neuroscience Institute Memory Center provides multidisciplinary care to patients with memory impairment and their families. Leading the care team at the multidisciplinary center are neurologist Gregory Cooper, M.D., Ph.D., and geriatrician Rachel N. Hart, D.O. “One of the benefits of the program like the one we’re creating is that we now become…
Gregory Cooper, M.D., Ph.D., neurologist and accomplished memory disorders researcher, has joined Norton Healthcare as medical director of the new Norton Neuroscience Institute Memory Center. Dr. Cooper was most recently medical director of memory care for Baptist Health in Lexington, Kentucky, his hometown. He is a faculty member at the University of Kentucky College of…
Time saved is brain saved, and in recent years we’ve gotten some more time to save more brain. In 2018, the American Heart and American Stroke associations updated their guidelines to say perfusion scanning can make more patients with ischemic stroke and large vessel occlusion eligible for treatment up to 24 hours after symptoms first…
A baseline concussion test provides data to measure functional change in an athlete, making it crucial to concussion care, according to Tad D. Seifert, M.D., a neurologist and sports concussion specialist who is director of the Norton Neuroscience Institute Sports Neurology Center. In addition to offering information about the athlete’s behavior when healthy, baseline concussion…
Stroke in young people has been increasing, with adults as young as in their 20s at risk. This largely is due to more young people having risk factors previously associated with the older population: a sedentary lifestyle, obesity, high cholesterol, hypertension, diabetes and sleep apnea. Women on birth control who smoke and experience migraines with…
Interventional procedures may provide an option for patients with episodic migraine in cases where oral medications may be contraindicated because of comorbidities or because they don’t provide sufficient relief. Many of these treatments do not have adequate studies to support their use, particularly to the degree that regulatory bodies and insurers would permit. There are…
In the past year, patients with relapsing forms of multiple sclerosis (MS) have gotten three new treatment options. Mavenclad (cladribine) is the most groundbreaking of the new drugs, in my opinion, due to its unique mechanism of action. Another drug, Mayzent (siponimod) became the first drug approved for active secondary progressive multiple sclerosis (SPMS). Active…
A new study published in Epilepsy Research found 64.3% of patients with various forms of drug-resistant epilepsy in the LAANTERN (Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System) registry were free of disabling seizures, reaching Engel I, after one year. Sixty patients were enrolled in the study specifically for epilepsy treatment. Forty-two reached…
When a suspected stroke patient comes into the hospital, everyone on the team has assigned roles so care is delivered quickly and efficiently — picture a race car pit crew jumping over the railing to change tires, add fuel, make repairs. They all have a rehearsed job to do with speed and safety the top…
A drug used to relieve a cluster headache cycle also can help with subsequent cycles if patients continue the therapy, according to a new study by Norton Neuroscience Institute neurologist Brian M. Plato, D.O. Episodic cluster headaches are severe headaches during periods of a week to several months. The headache cycles are separated by pain-free…
Join us Tuesday, Sept. 15, for a lunchtime series providing the latest updates in neuroscience. This program will be livestreamed from noon to 1 p.m. Mandy Whitt, M.D., headache specialist with Norton Neuroscience Institute, will discuss management and treatment options for migraines. Dr. Whitt will discuss the diagnostic criteria for migraine, the prevalence of migraine…